CME Listings
ResInsightsLive CME and Board Review Courses
Found 1 listing
Treatment Evolution for Patients with Idiopathic Pulmonary Fibrosis
ResInsightsLive
1
AMA PRA Category 1
Live Course; Enduring Material
Free
October 27, 2015 00:00
4/27/2016
Course Highlights: Select potential targets of the IPF disease process that can be leveraged for drug development
Review new antifibrotic drugs that extend survival and improve quality of life
Examine key diagnostic methods for definitive diagnosis of IPF
Identify the hallmark signs and symptoms of IPF
Explore the advances in defining pathologic features and molecular pathways activated in IPF